From $3.48 Billion to $5.20 Billion: Analyzing the Key Drivers and Clinical Innovations Propelling the Global Venlafaxine Market Through 2035
The journey of the global Venlafaxine market from a valuation of $3.48 billion in 2024 to a projected $5.20 billion by 2035 represents one of the most compelling growth narratives in the pharmaceutical sector focused on central nervous system (CNS) disorders. This robust expansion is not accidental but is a direct consequence of several interconnected clinical and societal drivers. At its core,...
0 نظرات 0 اشتراک‌گذاری‌ها 220 مشاهدات 0 نقد و بررسی‌ها